Precision Air’s Zero-particle Airflow System, SurgicAir® Zero, Debuts in Twin Cities Operating Rooms

Precision Air announced today the completion of its fourth SurgicAir® Zero O.R. Airflow System at TRIA Orthopedic Center Woodbury, a specialty orthopedic and urgent care facility in the Twin Cities metro area.

Precision Air advises this groundbreaking technology produces zero-particle air in operating rooms (O.R.s) and in health care settings, something that has never before been achieved. TRIA is currently testing it at their Woodbury location.

The SurgicAir® Zero System is a quantum leap in O.R. airflow quality – far exceeding today’s minimum standards. While numerous studies have proven airborne pathogens are a major source of contamination in the O.R., minimum codes for air quality have not kept up.

“TRIA’s investment in the SurgicAir® Zero System shows an innovative approach to infection control. The need for this Covid-capable technology is growing as health care leaders strive to protect patients and create a safe, comfortable experience for everyone in the room,” said Derek Weinschenk, Precision Air president.

This technology also enables TRIA to continue critical surgeries during the COVID-19 pandemic with fewer risks to surgical staff and patients. Testing data shows airborne contaminants from procedures like intubation or cauterization are more quickly controlled, leading to 75% less exposure for everyone in the room compared to basic ventilation systems.

Surgeons and health care leaders at TRIA who have implemented the system have shared their enthusiasm for the technology.

“Our SurgicAir® Zero System provides a comfortable, quiet O.R. environment. However, it is the peace of mind of having clean air in our surgical field that I find to be the largest benefit of this system,” said Dr. Gavin Pittman, orthopedic surgeon at TRIA Orthopedics.

“When we were planning for our TRIA Woodbury Surgery Center, we knew we wanted the latest technology for infection prevention. SurgicAir affords us additional protection for our patients with the cleanest air space above the operating table,” said Mary Haugen, director of TRIA’s ambulatory surgery centers.

In addition to the surgical suites at TRIA Woodbury, the SurgicAir® Zero Airflow System is currently operational at Presbyterian Hospital in New Mexico.

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The findings suggest that the novel, non-invasive genomic test can help physicians guide next steps for these patients, enabling them to potentially avoid unnecessary invasive procedures or accelerate time to appropriate treatment.
“These study results are highly encouraging especially given the short treatment duration of 10 days with BX004,” said Jonathan Solomon, Chief Executive Officer of BiomX. “In Part 2 of the study, BX004 showed clinically meaningful improvement in pulmonary function compared to placebo, as measured by relative FEV11 improvement (5.67% at Day 17, 1 week after end of treatment) and Cystic Fibrosis Questionnaire-Revised (CFQ-R) respiratory domain (8.87 points at Day 17) in a predefined subgroup of patients with reduced lung function.”  
Importantly, the study reported no serious treatment-related adverse events from any of the 109 patients treated with InGeneron’s Transpose® RT cell therapy system.
The decision cancels each of the original claims of the '345 Patent and declares unpatentable each of Swift's proposed substitute claims. Amongst the prior art deemed by the USPTO to render the '345 Patent unpatentable is a patent application licensed to MolecuLight that lists MolecuLight's Founder, Dr. Ralph DaCosta, as the sole inventor.
It combines the convenience of the Kaleido insulin pump with two market-leading innovations designed by Diabeloop and Dexcom to create a Hybrid Closed Loop system for managing type 1 diabetes which is flexible, self-learning and easy to use.

By using this website you agree to accept Medical Device News Magazine Privacy Policy